Skip to main content
Global
Global Fin Swe Nor Den Ger Cze Svk Pol Nld Bel (nl) Bel (fr) USA
Log in
  • Aidian – Your aid in diagnostics
  • Point-of-care testing
  • Products
  • About us
  • Insights hub
  • Antimicrobial resistance
  • Events
  • For distributors / Log in
Contact us Search
Logo
Contact us
  • Point of care
  • Microbiology
  • Hygiene monitoring
  • Molecular diagnostics
  • RIA / Collagens
  • Products available in the USA
Point of care
  • QuikRead go system
  • QuikRead 101
Read more
QuikRead go
  • QuikRead go Plus Instrument
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go accessories
QuikRead go
Microbiology
  • Uricult
  • Uricult Vet
  • Cultura M
Read more
Hygiene monitoring
  • Easicult
  • Hygicult
  • Cultura M
Read more
NEW! A comprehensive guide to monitoring surface hygiene now updated
Read more
Molecular diagnostics
  • SIBA
Read more
SIBA licensing and partnering opportunities
Read more
RIA / Collagens
  • UniQ
Read more
  • Our history
  • Board and management
  • Values and culture
  • Sustainability
  • Careers
  • Employee stories
  • Customer support
  • Partnering and licensing
  • UN Global Compact Commitment
  • Aidian logos
  • Health topics
  • Highlights
  • About C-reactive protein (CRP)
  • A guide to monitoring surface hygiene
  • Customer stories
  • News
  • AMR interview
  • Spreading of antibiotic resistant bacteria
  • Educational materials
  • Useful links
Modify Selected Code…
Contact us Close
  • Point-of-care testing
  • Products
    • Point of care
      • QuikRead go system
      • QuikRead 101
    • Microbiology
      • Uricult
      • Uricult Vet
      • Cultura M
    • Hygiene monitoring
      • Easicult
      • Hygicult
      • Cultura M
    • Molecular diagnostics
      • SIBA
    • RIA / Collagens
      • UniQ
    • Products available in the USA
  • About us
    • Our history
    • Board and management
    • Values and culture
    • Sustainability
    • Careers
    • Employee stories
    • Customer support
    • Partnering and licensing
    • UN Global Compact Commitment
    • Aidian logos
  • Insights hub
    • Health topics
      • Respiratory tract infections
      • Colorectal cancer
    • Highlights
      • From screening to triage: how quantitative FIT optimises colorectal cancer diagnostics
      • Point-of-care testing: supporting faster clinical decisions
      • Real-world insights on C-reactive protein point-of-care testing: lessons from a Belgian implementation study
    • About C-reactive protein (CRP)
      • CRP and lower respiratory tract infections
      • QuikRead go CRP products
    • A guide to monitoring surface hygiene
    • Customer stories
      • How a Swedish ambulance team makes confident decisions in the field with QuikRead go
      • Sleeping hygiene: monitoring cleanliness of pillows and bedding
    • News
  • Antimicrobial resistance
    • AMR interview
    • Spreading of antibiotic resistant bacteria
    • Educational materials
    • Useful links
  • Events
  • For distributors / Log in
Popular products
QuikRead go Plus Instrument

QuikRead go Plus Instrument

QuikRead go HbA1c

QuikRead go HbA1c

SIBA

SIBA

Latest news
View all

World AMR Awareness Week 2026 shines a spotlight on shared responsibility to prevent antimicrobial resistance

18 November 2026 | News, AMR

World Diabetes Day calls for early diagnosis and risk reduction

14 November 2026 | News

Rising West Nile virus cases highlight the need for diagnostic preparedness

10 September 2026 | News, Product news

  • View all
  • No results found
  • Loading...
News

World AMR Awareness Week 2026 shines a spotlight on shared responsibility to prevent antimicrobial resistance

18 November 2026 | News, AMR

World Diabetes Day calls for early diagnosis and risk reduction

14 November 2026 | News

Back to all news
18 November 2026
News,
AMR

World AMR Awareness Week 2026 shines a spotlight on shared responsibility to prevent antimicrobial resistance

18-24 November marks World AMR Awareness Week (WAAW) – an annual global campaign to raise awareness and understanding of antimicrobial resistance (AMR) and to promote global action to tackle the emergence and spread of drug-resistant infections. The theme for WAAW 2026 is “One Health, one action: Prevent AMR now”.1

Aidian takes part in supporting antimicrobial stewardship and sustainable use of antibiotics in primary care.

Antimicrobial resistance is a major global health threat

Antimicrobial resistance (AMR) means the ability of micro-organisms, including bacteria, viruses, fungi, and parasites, to resist treatment. In most cases, AMR specifically concerns antibiotic resistance, which occurs when bacteria develop the ability to withstand the effects of antibiotics.

AMR, also known as the Silent Pandemic, is one of the top global public health and development threats. It has been ranked among the top three priority health threats by the European Commission and Member States, and the World Health Organization (WHO) has listed AMR among the top 10 global health threats facing humanity.2-4 In 2021, bacterial AMR was estimated to be associated with more than 4.7 million deaths globally.5 Without urgent action, AMR could cause up to 39 million deaths by 2050.1

WHO reinforces global action against antimicrobial resistance

According to WHO's Global Antibiotic Resistance Surveillance Report 2025, resistance to life-saving medicines is critically high and rising. The report states that in 2023, approximately one in six laboratory-confirmed bacterial infections worldwide were caused by bacteria resistant to antibiotics.6 WHO warns of widespread resistance to common antibiotics worldwide – especially drug-resistant Gram-negative bacteria are becoming more dangerous worldwide.7

When drug-resistant pathogens emerge and spread, they affect human health, animal health, food security, economies, and sustainable development. Their emergence and spread are also influenced by the health of our environment.1 

In May 2026, WHO Member States adopted the updated Global action plan on antimicrobial resistance (GAP-AMR) 2026–2036, which is intended to serve as the global framework for coordinated action against AMR over the next decade. The adoption of the updated GAP-AMR reflects renewed global commitment to preserving the effectiveness of antimicrobials and safeguarding advances in human, animal and plant health, food security, economic development and environmental sustainability.8 The GAP-AMR calls on all countries and sectors to work together under a One Health approach to prevent and tackle AMR.1

The role of point-of-care testing in primary care

In healthcare, optimising antibiotic use is crucial to combating AMR: decreasing antibiotic overuse and providing antibiotics to those patients who benefit from the treatment. 

Respiratory tract infections are the most common reason for antibiotic prescribing in primary care, even though the majority of infections have viral cause or are self-limiting.9 Fast, accurate, and easy-to-use point-of-care (POC) diagnostic tests play an important role in optimising antibiotic prescribing for respiratory tract infections in healthcare.

CRP testing is a key tool against antibiotic overuse

C-reactive protein (CRP) point-of-care testing (POCT) is recognised as an essential tool in healthcare to guide rational use of antibiotics and prevent the development of antibiotic resistance. CRP POCT has several benefits in management of patients with respiratory tract infections in primary care:

  • provides immediate results for faster decisions
  • increases diagnostic certainty for physicians
  • targets antibiotic use for those patients who truly benefit from the treatment
  • reduces antibiotic use by approximately 23% in acute respiratory tract infections10

Learn more about antimicrobial resistance and our QuikRead go CRP test portfolio. 

 

References:

  1. World Health Organization (WHO). World AMR Awareness Week 2026: One Health, One Action: Prevent AMR Now. Available at https://www.who.int/news-room/events/detail/2026/11/18/default-calendar/world-amr-awareness-week-2026. Accessed 11.11.2026.
  2. European Commission. 'The silent pandemic': What is the EU doing to fight Antimicrobial Resistance? Available at: https://health.ec.europa.eu/publications/silent-pandemic-what-eu-doing-fight-antimicrobial-resistance_en. Accessed 11.11.2026.
  3. European Commission. EU Action on Antimicrobial Resistance. Available at https://health.ec.europa.eu/antimicrobial-resistance/eu-action-antimicrobial-resistance_en. Accessed 11.11.2026.
  4. World Health Organization (WHO). Ten threats to global health in 2019. Available at https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019. Accessed 11.11.2026.
  5. World Health Organization (WHO). Antimicrobial Resistance. Available at https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed 11.11.2026.
  6. World Health Organization (WHO). Global antibiotic resistance surveillance report 2025. Available at https://www.who.int/publications/i/item/9789240116337. Accessed 11.11.2026.
  7. World Health Organization (WHO). WHO warns of widespread resistance to common antibiotics worldwide. Available at https://www.who.int/news/item/13-10-2025-who-warns-of-widespread-resistance-to-common-antibiotics-worldwide. Accessed 11.11.2026.
  8. World Health Organization (WHO). The World Health Assembly adopts updated Global Action Plan on Antimicrobial Resistance (2026–2036). Available at https://www.who.int/news/item/25-05-2026-the-world-health-assembly-adopts-updated-global-action-plan-on-antimicrobial-resistance-(2026-2036). Accessed 11.11.2026.
  9. Bjerrum L et al. Health Alliance for Prudent Prescribing, Yield and Use of Antimicrobial Drugs in the Treatment of Respiratory Tract Infections (HAPPY AUDIT). BMC Fam Pract 2010; 11:29.
  10. Smedemark et al. Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care. Cochrane Database of Systematic Reviews 2022; 10: CD010130.
Share
Facebook
Twitter
Email

Aidian Oy

Koivu-Mankkaan tie 6 B
FI-02200 Espoo Finland
P.O. Box 83
FI-02101 Espoo Finland

 

+358 10 309 3000

Company
  • About us
  • Careers
  • Contact us
  • Events
  • Product-specific inquiries
  • Sales support
  • Sales related inquiries
  • Sustainability
Products
  • Point of care
  • Microbiology
  • Molecular diagnostics
  • Hygiene monitoring
  • RIA / Collagens
Quick links
  • Aidian Academy
  • Aidian Connect
  • Insights hub
  • IFU Revision histories
Copyright © 2026 Aidian
  • Privacy
  • Privacy Statements
  • Cookie Policy
  • Social Media Policy